**Core Concept**
The question tests knowledge of **anticoagulant medications**, specifically **direct thrombin inhibitors** used to prevent thrombosis. **Direct thrombin inhibitors** are a class of drugs that directly inhibit the activity of **thrombin**, a key enzyme in the coagulation cascade.

**Why the Correct Answer is Right**
The correct answer is a medication that directly inhibits **thrombin**, preventing the conversion of **fibrinogen** to **fibrin**, which is essential for clot formation. This class of drugs is useful in patients who require **anticoagulation** but may have issues with traditional anticoagulants like **warfarin**.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it is not specified.
**Option B:** Incorrect because it is not the latest.
**Option C:** Incorrect as it is an indirect inhibitor.

**Clinical Pearl / High-Yield Fact**
Remember that **direct thrombin inhibitors** have a predictable pharmacokinetic profile, which can be advantageous in certain clinical scenarios, such as in patients with **renal impairment** or those at risk for **bleeding complications**.

**Correct Answer:** D. Dabigatran.